Ident. | Authors (with country if any) | Title |
---|
000067 |
M. Lee [Canada] ; E. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | NEUROTOXINS RELEASED FROM INTERFERON-GAMMA-STIMULATED HUMAN ASTROCYTES |
000082 |
Maria Gabriela Sanchez [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys |
000137 |
S. Al Sweidi [Canada] ; M. G. Sanchez [Canada] ; M. Bourque [Canada] ; M. Morissette [Canada] ; D. Dluzen [États-Unis] ; T. Di Paolo [Canada] | Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson's Disease |
000164 |
D. W. Luchtman [Canada] ; Q. Meng [Canada] ; C. Song [Canada, République populaire de Chine] | Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease |
000256 |
Bazoumana Ouattara [Canada] ; Laurent Gregoire [Canada] ; Marc Morissette [Canada] ; Fabrizio Gasparini [Suisse] ; Ivo Vranesic [Suisse] ; Graeme Bilbe [Suisse] ; Donald R. Johns [Suisse] ; Alex Rajput [Canada] ; Oleh. Hornykiewicz [Autriche] ; Ali H. Rajput [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Therese Di Paolo [Canada] | Metabotropic glutamate receptor type 5 in levodopa-induced motor complications |
000308 |
Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada] | Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys |
000358 |
QINGJIA MENG [Canada] ; Dirk W. Luchtman [Canada] ; BOUCHAIB EL BAHH [Canada] ; Jeffrey A. Zidichouski [Canada] ; JUN YANG [Canada] ; CAI SONG [Canada] | Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices |
000375 |
C. Gibrat [Canada] ; M. Bousquet [Canada] ; M. Saint-Pierre [Canada] ; D. Levesque [Canada] ; F. Calon [Canada] ; C. Rouillard [Canada] ; F. Cicchetti [Canada] | Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor |
000384 |
B. Ouattara [Canada] ; D. Hoyer [Suisse] ; L. Gregoire [Canada] ; M. Morissette [Canada] ; F. Gasparini [Suisse] ; B. Gomez-Mancilla [Suisse] ; T. Di Paolo [Canada] | CHANGES OF AMPA RECEPTORS IN MPTP MONKEYS WITH LEVODOPA-INDUCED DYSKINESIAS |
000433 |
M. Bousquet [Canada] ; C. Gibrat [Canada] ; M. Saint-Pierre [Canada] ; C. Julien [Canada] ; F. Calon [Canada] ; F. Cicchetti [Canada] | Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model |
000480 |
Sandra Lourenssen [Canada] ; Kurtis G. Miller [Canada] ; Michael G. Blennerhassett [Canada] | Discrete responses of myenteric neurons to structural and functional damage by neurotoxins in vitro |
000491 |
Dirk W. Luchtman [Canada] ; DI SHAO [Canada] ; CAI SONG [Canada] | Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease |
000500 |
Laurent Gregoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [États-Unis] ; Pershia Samadi [Canada] ; Paul J. Bedard [Canada] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Therese Di Paolo [Canada] | Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys |
000716 |
Reyniel Cruz-Aguado [Canada] ; Daniella Winkler ; Christopher A. Shaw | Lack of behavioral and neuropathological effects of dietary β-methylamino-L-alanine (BMAA) in mice |
000747 |
Maryka Quik [États-Unis] ; Neeraja Parameswaran [États-Unis] ; Sarah E. Mccallum [États-Unis] ; Tanuja Bordia [États-Unis] ; SHANSHAN BAO [États-Unis] ; Alison Mccormack [États-Unis] ; Amy Kim [États-Unis] ; Rachel F. Tyndale [Canada] ; J. William Langston [États-Unis] ; Donato A. Di Monte [États-Unis] | Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates |
000768 |
Thomas E. Marler [États-Unis] ; Vivian Lee [Canada] ; Christopher A. Shaw [Canada] | Spatial variation of steryl glucosides in Cycas micronesica plants : Within- and among-plant sampling procedures |
000782 |
Shawn Hayley [Canada] ; Hymie Anisman [Canada] | Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action |
000786 |
Wiplove Lamba [Canada] ; Wendy Prichett [Canada] ; David Munoz [Canada] ; David S. Park [Canada] ; John M. Woulfe [Canada] | MPTP induces intranuclear rodlet formation in midbrain dopaminergic neurons |
000806 |
Thomas E. Marler [États-Unis] ; Vivian Lee [Canada] ; Christopher A. Shaw [Canada] | Cycad toxins and neurological diseases in guam : Defining theoretical and experimental standards for correlating human disease with environmental toxins |
000871 |
Erwan Bezard [France] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Anne Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque |
000938 |
Jackalina Van Kampen [Canada] ; Harold Robertson [Canada] ; Theo Hagg [Canada] ; Robert Drobitch [Canada] | Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease |
000950 |
LI LIU [Canada] ; Shu S. Hsu [Canada] ; Suneil K. Kalia [Canada] ; Andres M. Lozano [Canada] | Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP |
000999 |
MYUNG AE LEE [Corée du Sud] ; Hye-Souk Lee [Corée du Sud] ; HYUN SOO LEE [Corée du Sud] ; Kyung G. Cho [Corée du Sud] ; BYUNG KWAN JIN [Corée du Sud] ; Seonghyang Sohn [Corée du Sud] ; YOUNG SEEK LEE [Corée du Sud] ; Hiroshi Ichinose [Japon] ; SEUNG UP KIM [Corée du Sud, Canada] | Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins |
000A11 |
I. Khabazian [Canada] ; J. S. Bains [Canada] ; D. E. Williams [Canada] ; J. Cheung [Canada] ; J. M. B. Wilson [Canada] ; B. A. Pasqualotto [Canada] ; S. L. Pelech [Canada] ; R. J. Andersen [Canada] ; Y.-T. Wang [Canada] ; L. Liu [Canada] ; A. Nagai [Canada] ; S. U. Kim [Canada] ; U-K. Craig ; C. A. Shaw [Canada] | Isolation of various forms of sterol β-d-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex |
000A21 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
000B09 |
W. Maruyama [Japon] ; A. A. Boulton [Canada] ; B. A. Davis [Canada] ; P. Dostert [France] ; M. Naoi [Japon] | Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells : Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine |
000B89 |
Maria C. Yang [Canada] ; Allan J. Mclean [Canada] ; Laurent P. Rivory [Australie] ; David G. Le Couteur [Canada] | Hepafic disposition of neurotoxins and pesticides |
000C56 |
T. Inoue [Canada, Japon] ; J. Tsui [Canada] ; N. Wong [Canada] ; SHIN YI WONG [Canada] ; F. Suzuki [Japon] ; YIN NAM KWOK [Canada] | Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment |
000C69 |
F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys : effects on basal ganglia GABAA/ benzodiazepine receptor complex and GABA content |
000D77 |
C. Thiffault [Canada] ; L. Lamarre-Theroux [Canada] ; R. Quirion [Canada] ; J. Poirier [Canada] | L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse |
000D78 |
N. A. Tatton [Canada] ; S. J. Kish [Canada] | In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and Acridine Orange Staining |
000D79 |
I. Q. Whishaw [Canada] ; B. L. K. Coles [Canada] ; S. M. Pellis [Canada] ; E. I. Miklyaeva [Canada] | Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease |
000E22 |
J.-J. Soghomonian [Canada] ; S. Pedneault [Canada] ; P. J. Blanchet [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada] | L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys |
000E23 |
D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada] | In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates |
000E28 |
M. Goulet [Canada] ; R. Grondin ; P. J. Blanchet ; P. J. Bedard ; T. Di Paolo [Canada] | Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode to not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys |
000E67 |
C. Thiffault [Canada] ; N. Aumont ; R. Quirion [Canada] ; J. Poirier | Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain |
000E80 |
R. Kanthan [Canada] ; A. Shuaib ; G. Goplen ; H. Miyashita | A new method of in-vivo microdialysis of the human brain |
000E90 |
K. H. Jhamandas [Canada] ; R. J. Boegman [Canada] ; R. J. Beninger | The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits : modulation by endogenous excitotoxin antagonists |
000F10 |
P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. Bedard | Excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys |
000F36 |
M. Takada [Canada] ; T. Sugimoto ; T. Hattori [Canada] | MPTP neurotoxicity to cerebellar Purkinje cells in mice |
001015 |
W. G. Tatton [Canada] ; C. E. Greenwood | Rescue of dying neurons : a new action for deprenyl in MPTP parkinsonism |
001021 |
D. B. Calne [Canada] | Neurotoxins and degeneration in the central nervous system |
001079 |
T. L. Perry ; C. Bergeron ; A. J. Biro ; S. Hansen | β-N-methylamino-L-alanine: chronic oral administration is not neurotoxic to mice |
001085 |
L. Tremblay ; M. Filion ; P. J. Bedard | Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism |
001131 |
T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall | 2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease |
001149 |
T. L. Perry ; S. Hansen ; K. Jones | Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice |